These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 23615975)

  • 21. Serotonin-2C and -2a receptor co-expression on cells in the rat medial prefrontal cortex.
    Nocjar C; Alex KD; Sonneborn A; Abbas AI; Roth BL; Pehek EA
    Neuroscience; 2015 Jun; 297():22-37. PubMed ID: 25818050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5-HT2C receptor blockade reverses SSRI-associated basal ganglia dysfunction and potentiates therapeutic efficacy.
    Demireva EY; Suri D; Morelli E; Mahadevia D; Chuhma N; Teixeira CM; Ziolkowski A; Hersh M; Fifer J; Bagchi S; Chemiakine A; Moore H; Gingrich JA; Balsam P; Rayport S; Ansorge MS
    Mol Psychiatry; 2020 Dec; 25(12):3304-3321. PubMed ID: 30120415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of ketanserin and amphetamine on nigrostriatal neurotransmission and reactive oxygen species in Parkinsonian rats. In vivo microdialysis study.
    Nowak P; Szczerbak G; Biedka I; Drosik M; Kostrzewa RM; Brus R
    J Physiol Pharmacol; 2006 Dec; 57(4):583-97. PubMed ID: 17229983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-HT2C receptor binding is increased in the substantia nigra pars reticulata in Parkinson's disease.
    Fox SH; Brotchie JM
    Mov Disord; 2000 Nov; 15(6):1064-9. PubMed ID: 11104187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gq/5-HT2c receptor signals activate a local GABAergic inhibitory feedback circuit to modulate serotonergic firing and anxiety in mice.
    Spoida K; Masseck OA; Deneris ES; Herlitze S
    Proc Natl Acad Sci U S A; 2014 Apr; 111(17):6479-84. PubMed ID: 24733892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Distinct roles of the direct and indirect pathways in the basal ganglia circuit mechanism].
    Morita M; Hikida T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2015 Nov; 35(5-6):107-11. PubMed ID: 26785520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fine-tuning serotonin2c receptor function in the brain: molecular and functional implications.
    Berg KA; Clarke WP; Cunningham KA; Spampinato U
    Neuropharmacology; 2008 Nov; 55(6):969-76. PubMed ID: 18602407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serotonin2C Receptors and the Motor Control of Oral Activity.
    Lagière M; Navailles S; Bosc M; Guthrie M; Deurwaerdère PD
    Curr Neuropharmacol; 2013 Mar; 11(2):160-70. PubMed ID: 23997751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of Serotonin2C Receptors in Pyramidal and GABAergic Neurons of Rat Prefrontal Cortex: A Comparison with Striatum.
    Santana N; Artigas F
    Cereb Cortex; 2017 Jun; 27(6):3125-3139. PubMed ID: 27252352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Purposeless oral activity induced by meta-chlorophenylpiperazine (m-CPP): Undefined tic-like behaviors?
    Kreiss DS; De Deurwaerdère P
    J Neurosci Methods; 2017 Dec; 292():30-36. PubMed ID: 28483714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective increases in serotonin 5-HT1B/1D and 5-HT2A/2C binding sites in adult rat basal ganglia following lesions of serotonergic neurons.
    Compan V; Segu L; Buhot MC; Daszuta A
    Brain Res; 1998 May; 793(1-2):103-11. PubMed ID: 9630549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The serotonin 5-HT2C receptor is a prominent serotonin receptor in basal ganglia: evidence from functional studies on serotonin-mediated phosphoinositide hydrolysis.
    Wolf WA; Schutz LJ
    J Neurochem; 1997 Oct; 69(4):1449-58. PubMed ID: 9326273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parkinson's disease--opportunities for novel therapeutics to reduce the problems of levodopa therapy.
    Fox SH; Chuang R; Brotchie JM
    Prog Brain Res; 2008; 172():479-94. PubMed ID: 18772047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of adenosine receptors with other receptors from therapeutic perspective in Parkinson's disease.
    Morin N; Di Paolo T
    Int Rev Neurobiol; 2014; 119():151-67. PubMed ID: 25175965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of serotonin 5-HT2C receptors in GABAergic cells of the anterior raphe nuclei.
    Serrats J; Mengod G; Cortés R
    J Chem Neuroanat; 2005 Mar; 29(2):83-91. PubMed ID: 15652696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Localization and physiological roles of metabotropic glutamate receptors in the direct and indirect pathways of the basal ganglia.
    Marino MJ; Awad H; Poisik O; Wittmann M; Conn PJ
    Amino Acids; 2002; 23(1-3):185-91. PubMed ID: 12373536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5-HT
    Peng Y; McCorvy JD; Harpsøe K; Lansu K; Yuan S; Popov P; Qu L; Pu M; Che T; Nikolajsen LF; Huang XP; Wu Y; Shen L; Bjørn-Yoshimoto WE; Ding K; Wacker D; Han GW; Cheng J; Katritch V; Jensen AA; Hanson MA; Zhao S; Gloriam DE; Roth BL; Stevens RC; Liu ZJ
    Cell; 2018 Feb; 172(4):719-730.e14. PubMed ID: 29398112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Region-dependent regulation of mesoaccumbens dopamine neurons in vivo by the constitutive activity of central serotonin2C receptors.
    Navailles S; Moison D; Ryczko D; Spampinato U
    J Neurochem; 2006 Nov; 99(4):1311-9. PubMed ID: 17018023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The distribution of excitatory amino acid receptors in the normal human midbrain and basal ganglia with implications for Parkinson's disease: a quantitative autoradiographic study using [3H]MK-801, [3H]glycine, [3H]CNQX and [3H]kainate.
    Ball EF; Shaw PJ; Ince PG; Johnson M
    Brain Res; 1994 Sep; 658(1-2):209-18. PubMed ID: 7834343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Basal Ganglia Neuromodulation Over Multiple Temporal and Structural Scales-Simulations of Direct Pathway MSNs Investigate the Fast Onset of Dopaminergic Effects and Predict the Role of Kv4.2.
    Lindroos R; Dorst MC; Du K; Filipović M; Keller D; Ketzef M; Kozlov AK; Kumar A; Lindahl M; Nair AG; Pérez-Fernández J; Grillner S; Silberberg G; Hellgren Kotaleski J
    Front Neural Circuits; 2018; 12():3. PubMed ID: 29467627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.